{
    "moduleId": "module_17",
    "moduleTitle": "L2: Complex Client Scenarios",
    "passingScore": 80,
    "questions": [
        {
            "id": "q17_1",
            "question": "A 52-year-old client with Hashimoto's thyroiditis reports increased fatigue, anxiety, and irregular periods. Her TSH is within the normal range, but she is experiencing significant menopausal symptoms. Which of the following is the MOST appropriate initial step?",
            "options": ["Immediately prescribe HRT.", "Increase her thyroid medication dosage.", "Assess for other potential causes of her symptoms, such as iron deficiency or vitamin D deficiency.", "Recommend a strict elimination diet."],
            "correctAnswer": 2,
            "explanation": "While HRT might be considered, it's crucial to rule out other potential causes of her symptoms first, especially considering her autoimmune condition. Addressing nutritional deficiencies is often a necessary first step."
        },
        {
            "id": "q17_2",
            "question": "A 55-year-old client with a history of breast cancer (treated with lumpectomy and radiation) is experiencing severe vaginal dryness and dyspareunia. She is hesitant to use hormonal therapies. Which of the following is the MOST appropriate recommendation?",
            "options": ["Systemic HRT is the only effective treatment.", "Vaginal estrogen is contraindicated in women with a history of breast cancer.", "Non-hormonal vaginal moisturizers and lubricants should be the first-line treatment.", "Recommend she see a psychiatrist for her pain."],
            "correctAnswer": 2,
            "explanation": "Non-hormonal options are preferred first-line treatments for GSM in women with a history of breast cancer. Vaginal estrogen may be considered after careful discussion of risks and benefits."
        },
        {
            "id": "q17_3",
            "question": "According to studies discussed in the module, what percentage of women experience sleep disturbances during perimenopause?",
            "options": ["Approximately 10%", "Approximately 25%", "Approximately 40-60%", "Approximately 80%"],
            "correctAnswer": 2,
            "explanation": "Research indicates that 40-60% of women report sleep disturbances during the perimenopausal transition, often linked to hormonal fluctuations and vasomotor symptoms."
        },
        {
            "id": "q17_4",
            "question": "A 48-year-old client with a history of major depressive disorder, well-managed with an SSRI, reports increased mood swings and anxiety coinciding with irregular periods. What is the MOST appropriate initial approach?",
            "options": ["Increase the dosage of her SSRI.", "Immediately prescribe HRT.", "Assess for perimenopausal symptoms and consider a trial of low-dose estrogen if appropriate, while closely monitoring her mental health.", "Refer her to a psychiatrist for a medication change."],
            "correctAnswer": 2,
            "explanation": "While adjusting the SSRI or psychiatric referral may be necessary, it's important to assess for perimenopause and consider the potential benefit of HRT, with careful monitoring due to her history of depression."
        },
        {
            "id": "q17_5",
            "question": "Which of the following cardiovascular risk factors is MOST significantly impacted by the menopausal transition?",
            "options": ["Total cholesterol", "LDL cholesterol", "HDL cholesterol", "Triglycerides"],
            "correctAnswer": 1,
            "explanation": "LDL cholesterol tends to increase during menopause due to estrogen decline, increasing cardiovascular risk. While other lipid parameters may also be affected, the increase in LDL is particularly noteworthy."
        },
        {
            "id": "q17_6",
            "question": "A 50-year-old client reports significant weight gain, particularly around her abdomen, despite maintaining her usual diet and exercise routine. She also complains of fatigue and brain fog. What hormonal change is MOST likely contributing to these symptoms?",
            "options": ["Increased estrogen", "Decreased testosterone", "Increased progesterone", "Decreased estrogen"],
            "correctAnswer": 3,
            "explanation": "Decreased estrogen levels during perimenopause can lead to metabolic changes, including increased abdominal fat storage, fatigue, and cognitive difficulties."
        },
        {
            "id": "q17_7",
            "question": "A client undergoing treatment for breast cancer asks about using black cohosh for hot flashes. What is the MOST appropriate response?",
            "options": ["Black cohosh is safe and effective for all women with hot flashes.", "Black cohosh is contraindicated for all women with a history of cancer.", "The safety and efficacy of black cohosh in women with a history of breast cancer is uncertain, and should be discussed with her oncologist.", "Black cohosh is more effective than HRT for hot flashes."],
            "correctAnswer": 2,
            "explanation": "Due to conflicting data and potential estrogenic effects, the use of black cohosh in women with a history of breast cancer should be carefully considered in consultation with their oncologist."
        },
        {
            "id": "q17_8",
            "question": "A 58-year-old client presents with urinary urgency, frequency, and recurrent UTIs. She has tried vaginal estrogen without significant improvement. What additional condition should be considered?",
            "options": ["Interstitial cystitis", "Overactive bladder", "Pelvic floor dysfunction", "All of the above"],
            "correctAnswer": 3,
            "explanation": "Urinary symptoms in postmenopausal women can be multifactorial. Interstitial cystitis, overactive bladder, and pelvic floor dysfunction are all potential contributing factors that should be evaluated."
        },
        {
            "id": "q17_9",
            "question": "Which of the following statements regarding the ethical considerations of prescribing HRT is MOST accurate?",
            "options": ["It is always ethical to prescribe HRT if a client requests it.", "Clinicians should only prescribe HRT if they are certain it will benefit the client.", "Clinicians should engage in shared decision-making, discussing the risks and benefits of HRT with the client, while respecting their autonomy.", "Ethical considerations are not relevant when prescribing HRT."],
            "correctAnswer": 2,
            "explanation": "Shared decision-making, including a comprehensive discussion of risks and benefits and respecting patient autonomy, is crucial for ethical HRT prescribing."
        },
        {
            "id": "q17_10",
            "question": "A 49-year-old client, with a BMI of 32 and a history of gestational diabetes, is experiencing hot flashes and night sweats. She is concerned about weight gain and cardiovascular risk during perimenopause. What is the MOST important lifestyle recommendation?",
            "options": ["Start a ketogenic diet.", "Increase saturated fat intake.", "Engage in regular physical activity, including both aerobic and resistance training, and adopt a balanced, whole-foods diet.", "Take weight loss supplements."],
            "correctAnswer": 3,
            "explanation": "Lifestyle interventions, including exercise and a healthy diet, are crucial for managing weight, improving cardiovascular health, and alleviating menopausal symptoms in women with obesity and a history of gestational diabetes."
        }
    ]
}